Hypertrophic cardiomyopathy: The need for randomized trials

Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition characterized by variable degrees of asymmetric left ventricular (LV) hypertrophy, generally associated with mutations in sarcomere protein genes. While generally perceived as rare, HCM is the most common genetic heart disease with ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Olivotto, Iacopo, Tomberli, Benedetta, Spoladore, Roberto, Mugelli, Alessandro, Cecchi, Franco, Camici, Paolo G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bloomsbury Qatar Foundation Journals 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963756/
https://www.ncbi.nlm.nih.gov/pubmed/24689025
http://dx.doi.org/10.5339/gcsp.2013.31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963756/
https://www.ncbi.nlm.nih.gov/pubmed/24689025
http://dx.doi.org/10.5339/gcsp.2013.31

Ejemplares similares